Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00122096 · ClinicalTrials.gov registry record · Phase 4
Perioperative Inflammation and Cyclooxygenase 2 (COX-2)
A Phase 4 study of Pain and Neurosurgery, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00122096: Completed Phase 4 study of Pain and Neurosurgery, sponsored by University of Washington.
NCT00122096 is a Phase 4 study of Pain and Neurosurgery that has completed, run by University of Washington. The registered enrollment target is 30 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00122096, a Phase 4 study of Pain and Neurosurgery, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Surgery initiates a complex cascade of events involving the release of chemical compounds from nerve endings and damaged tissue which leads to an inflammatory and pain response. The purpose of this investigation is to measure various chemical mediators in the blood and cerebrospinal fluid, and to test the hypothesis that they will be decreased in patients treated with a COX-2 inhibitor.
Conditions Studied
Interventions
- DRUG valdecoxib
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2002-11 |
| Est. Completion | 2006-01 |
| Phase | Phase 4 |
What the finished NCT00122096 record still lists
NCT00122096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which valdecoxib is the first listed.
NCT00122096 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00122096 about?
NCT00122096 is a clinical study titled "Perioperative Inflammation and Cyclooxygenase 2 (COX-2)". Surgery initiates a complex cascade of events involving the release of chemical compounds from nerve endings and damaged tissue which leads to an inflammatory and pain response. The purpose of this investigation is to measure various chemical mediators in the blood and cerebrospinal fluid, and to te...
What is the current status of trial NCT00122096?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2002-11. Estimated completion is 2006-01.
What conditions does trial NCT00122096 study?
This clinical trial studies the following conditions: Pain, Neurosurgery.
What interventions are being tested in trial NCT00122096?
The interventions under investigation include: valdecoxib (DRUG).
Who is sponsoring clinical trial NCT00122096?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00122096 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00122096's enrollment target sits among peer trials
30 310th of 374 higher than 60 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia